CR20160188A - Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido - Google Patents

Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido

Info

Publication number
CR20160188A
CR20160188A CR20160188A CR20160188A CR20160188A CR 20160188 A CR20160188 A CR 20160188A CR 20160188 A CR20160188 A CR 20160188A CR 20160188 A CR20160188 A CR 20160188A CR 20160188 A CR20160188 A CR 20160188A
Authority
CR
Costa Rica
Prior art keywords
solution
solutions
organ
stability
increase
Prior art date
Application number
CR20160188A
Other languages
English (en)
Inventor
Mahendra Suryan
Original Assignee
Somahlution Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somahlution Llc filed Critical Somahlution Llc
Publication of CR20160188A publication Critical patent/CR20160188A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/126Physiologically active agents, e.g. antioxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/063Glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Se divulgan soluciones de conservación de tejido y órganos que tienen mejorada establidad. Las soluciones están compuestas por dos soluciones separadas. La primera solución, Solución A, está compuesta por una solución salina balanceada que es estable en solución a un pH de 7,0 o superior. Una segunda solución, solución B, está compuesta por una solución acuosa que contiene L-glutationa y/o cisteinilglicina, un azúcar tal como D-Glucosa, L-Arginina, un agente reductor tal como ácido ascórbico y agua, a un pH inferior a 7,0, preferentemente, de alrededor de 3,0 a 5,0.
CR20160188A 2013-11-22 2016-04-22 Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido CR20160188A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361963093P 2013-11-22 2013-11-22
PCT/US2014/066054 WO2015077199A1 (en) 2013-11-22 2014-11-18 Solutons for increasing the stability and shelf life of an organ tissue preservation solution

Publications (1)

Publication Number Publication Date
CR20160188A true CR20160188A (es) 2016-07-04

Family

ID=52023642

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160188A CR20160188A (es) 2013-11-22 2016-04-22 Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido

Country Status (23)

Country Link
US (2) US11291201B2 (es)
EP (1) EP3027016B1 (es)
JP (1) JP2016537333A (es)
KR (2) KR102570322B1 (es)
CN (1) CN105916374B (es)
AR (1) AR098508A1 (es)
AU (1) AU2014353199B2 (es)
BR (1) BR112016006512B1 (es)
CA (1) CA2923441C (es)
CL (1) CL2016001003A1 (es)
CR (1) CR20160188A (es)
DK (1) DK3027016T3 (es)
EA (1) EA201691066A1 (es)
ES (1) ES2744637T3 (es)
IL (1) IL244834B (es)
MX (1) MX378411B (es)
MY (1) MY181282A (es)
PE (1) PE20160861A1 (es)
PH (1) PH12016500909B1 (es)
SG (1) SG10201709595WA (es)
TW (1) TW201605342A (es)
WO (1) WO2015077199A1 (es)
ZA (2) ZA201602253B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105916374B (zh) * 2013-11-22 2021-11-05 索玛解有限公司 用于增加器官和组织保存溶液的稳定性和储存寿命的溶液
WO2018081213A1 (en) 2016-10-25 2018-05-03 Marquette University Storage media and powder formulations for avulsed teeth and explanted tissues comprising fibroblasts
US11980700B2 (en) 2017-03-08 2024-05-14 Alafair Biosciences, Inc. Hydrogel medium for the storage and preservation of tissue
EP4507493A1 (en) 2022-04-15 2025-02-19 Marizyme, Inc. Powder formulations and use thereof in medical and/or surgical procedures
US20250270515A1 (en) 2022-05-16 2025-08-28 Marizyme, Inc. Use of cytoprotectant formulations in cell or tissue transport and/or storage
WO2024076634A1 (en) 2022-10-04 2024-04-11 Marizyme, Inc. Kits and use thereof in surgical procedures for endoscopic harvesting of vessels

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443432A (en) 1981-10-05 1984-04-17 Alcon Laboratories, Inc. Ophthmalic irrigating solution
US4550022A (en) 1981-10-05 1985-10-29 Alcon Laboratories, Inc. Tissue irrigating solution
US5409904A (en) 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4879283A (en) 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
US4837021A (en) 1986-12-31 1989-06-06 Laboratoires P.O.S. Two part tissue irrigating solution
US5304724A (en) 1988-09-09 1994-04-19 Entravision, Inc. Tissue irrigating solution
US4938961A (en) 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia
US5257985A (en) 1989-12-04 1993-11-02 Richard Puhl Multi-chamber intravenous bag apparatus
US5066578A (en) * 1989-12-21 1991-11-19 The Regents Of The University Of California Long-term preservation of organs for transplantation
JPH05503944A (ja) * 1990-11-07 1993-06-24 バクスター、インターナショナル、インコーポレイテッド 血小板貯蔵媒質
JP3185108B2 (ja) * 1990-11-07 2001-07-09 バクスター、インターナショナル、インコーポレイテッド 赤血球貯蔵溶液
US5498427A (en) 1990-11-20 1996-03-12 Pasteur Merieux Serums Et Vaccines Solutions for the perfusion, preservation and reperfusion of organs
AU664074B2 (en) * 1992-06-26 1995-11-02 Torii Pharmaceutical Co., Ltd. Organ preserving fluid
CH686870A5 (fr) 1992-09-18 1996-07-31 Pasteur Merieux Serums Vacc Solution de perfusion, de conservation et de reperfusion d'organes.
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
JP3623294B2 (ja) 1995-11-28 2005-02-23 株式会社新素材総合研究所 電解質液が収容された医療用容器及びその製造方法
US8409846B2 (en) * 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6153582A (en) 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
US7611830B2 (en) 2000-04-10 2009-11-03 The United States Of America As Represented By The Department Of Veteran's Affairs Device to lavage a blood vessel
US6569615B1 (en) 2000-04-10 2003-05-27 The United States Of America As Represented By The Department Of Veteran's Affairs Composition and methods for tissue preservation
SI21704A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
US20060093765A1 (en) 2004-10-29 2006-05-04 Sealed Air Corporation (Us) Multi-compartment pouch having a frangible seal
US20060160062A1 (en) 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US7575856B2 (en) 2005-10-28 2009-08-18 The United States Of America As Represented By The Department Of Veterans Affairs Compositions and methods for the evaluation and resuscitation of cadaveric hearts for transplant
ES2772676T3 (es) * 2006-04-19 2020-07-08 Transmedics Inc Sistema de cuidado de órganos ex vivo
EP2543249B1 (en) 2007-02-17 2018-05-23 President and Fellows of Harvard College Compositions and method for tissue preservation
US20090035240A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
US9918951B2 (en) * 2008-02-05 2018-03-20 Kyowa Hakko Bio Co., Ltd. Method for improving storage stability of glutathione
US20110059177A1 (en) 2008-02-15 2011-03-10 Hemant Thatte Cardioplegia Solution for Cardiac Surgery
US8608922B2 (en) 2008-11-07 2013-12-17 The University Of Connecticut Biosensor for continuous monitoring of metabolites and proteins and methods of manufacture thereof
EP2355806A2 (en) 2008-11-14 2011-08-17 Profimed s.r.o. Non-aqueous colloidal formulation
US8288084B2 (en) 2009-07-12 2012-10-16 Revive Organtech, Inc. Composition and method for flushing and cold/cryo preserving organs, tissues, and cells
US10207022B2 (en) * 2009-09-01 2019-02-19 Medoderm Gmbh Chitosan tissue dressing
FR2963965B1 (fr) 2010-08-20 2013-02-15 Vallourec Mannesmann Oil & Gas Procede et dispositif de controle d'un filetage de joint tubulaire utilise dans l'industrie du petrole
BR112015015090A2 (pt) 2012-12-31 2017-07-11 Somahlution Llc processos para preservar a função de tecido ou de órgão e para preparar formulação para a mesma e kit respectivo
TW201428113A (zh) * 2013-01-09 2014-07-16 三菱綜合材料股份有限公司 電子/電氣機器用銅合金、電子/電氣機器用銅合金薄板、電子/電氣機器用銅合金之製造方法、電子/電氣機器用導電零件及端子
CA2910189A1 (en) 2013-04-24 2014-10-30 Somahlution, Llc Organ and tissue preservation solutions having increased oxygen-content, stability and shelf life
JP2016520580A (ja) 2013-04-29 2016-07-14 ソマールション・エルエルシー 臓器及び組織の保存溶液の酸素含量、安定性、及び貯蔵寿命を増大させるための、ポリ(0−2−ヒドロキシエチル)デンプンを含有する製剤
CN105916374B (zh) * 2013-11-22 2021-11-05 索玛解有限公司 用于增加器官和组织保存溶液的稳定性和储存寿命的溶液

Also Published As

Publication number Publication date
CN105916374A (zh) 2016-08-31
MY181282A (en) 2020-12-21
TW201605342A (zh) 2016-02-16
MX378411B (es) 2025-03-10
IL244834B (en) 2021-06-30
KR102570322B1 (ko) 2023-08-23
KR102428676B1 (ko) 2022-08-03
SG10201709595WA (en) 2017-12-28
HK1220081A1 (en) 2017-04-28
CA2923441C (en) 2023-03-28
EP3027016A1 (en) 2016-06-08
BR112016006512B1 (pt) 2021-11-23
AU2014353199A1 (en) 2016-04-14
EP3027016B1 (en) 2019-06-12
PH12016500909A1 (en) 2016-06-20
CN105916374B (zh) 2021-11-05
US20160249603A1 (en) 2016-09-01
AR098508A1 (es) 2016-06-01
PH12016500909B1 (en) 2019-09-18
BR112016006512A2 (pt) 2017-08-01
JP2016537333A (ja) 2016-12-01
ES2744637T3 (es) 2020-02-25
IL244834A0 (en) 2016-05-31
ZA201602253B (en) 2025-05-28
PE20160861A1 (es) 2016-09-03
CA2923441A1 (en) 2015-05-28
US11291201B2 (en) 2022-04-05
EA201691066A1 (ru) 2016-09-30
DK3027016T3 (da) 2019-09-16
WO2015077199A1 (en) 2015-05-28
KR20220111736A (ko) 2022-08-09
AU2014353199B2 (en) 2018-07-19
MX2016006651A (es) 2016-09-06
CL2016001003A1 (es) 2016-12-02
KR20160093636A (ko) 2016-08-08
US20220232822A1 (en) 2022-07-28
ZA202210899B (en) 2024-02-28

Similar Documents

Publication Publication Date Title
CR20160188A (es) Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido
MX372703B (es) Jabon liquido que tiene actividad antibacteriana mejorada.
MX2015008529A (es) Solucion para conservar conductos vasculares.
MX2021009652A (es) Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel.
EP3437628A4 (en) COSMETIC COMPOSITION USING ALBUMINE, HYALURONIC ACID OR COLLAGEN AS AN ACTIVE IN CELL CULTURE MEDIUM
PE20161172A1 (es) Complejos de cobre-amonio y de cobre-zinc-amonio solubilizados con acidos, composiciones, preparaciones, metodos y usos
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
CL2012003488A1 (es) Formulación intravenosa que comprende una solución acuosa de sulfobutil-eter-beta-ciclodextrina y amiodarona o una sal en proporción entre 2,7: 1 a 7:1; metodo de preparación; un artículo manufacturado, util en arritmias.
BR112015026685A2 (pt) agente de diminuição de ácido úrico
BR112015026077A8 (pt) barra de sabão, método de redução de bactérias gram positivas e uso de uma barra de sabão
MX345216B (es) Solucion oftalmica que contiene acido hialuronico o sal del mismo y propilenglicol.
RU2010129784A (ru) Способ приготовления противотуберкулезного лекарственного препарата
TH172594A (th) วิธีแก้ปัญหาสำหรับการเพิ่มเสถียรภาพและอายุการเก็บบนชั้นของสารละลาย การเก็บถนอมเนื้อเยื่อและอวัยวะ
MX2021012395A (es) Solucion de acido ascorbico estable con un contenido elevado de agua.
PL399978A1 (pl) Zastosowanie kompozycji 3-bromopirogronianu jako leku drugiego zastosowania w terapii grzybic
TH161382A (th) องค์ประกอบที่เป็นน้ำที่ประกอบด้วยกรด 2-อะมิโน-3-(4-โบรโมเบนโซอิล) ฟีนิลอะซีติก
MX2015008549A (es) Tratamiento microbicida para frutas y verduras comestibles.
TH168841A (th) องค์ประกอบที่ใช้สำหรับช่องปากและสารลดภาวะเครียดออกซิเดชัน
RU2013153124A (ru) Сироп, обладающий противовирусным действием
TH162256A (th) ตัวยับยั้งการตายของเซลล์เนื้อเยื่อบุผิวของกระจกตาซึ่งมีฟลาวินแอดีนีนไดนิวคลีโอไทด์หรือเกลือของสิ่งเหล่านี้ในฐานะเป็นสารออกฤทธิ์
MX353555B (es) Composiciones acuosas que contienen la sal de potasio del acido (s)-(+)-abscisico.
UA88421U (ru) Фармацевтическая композиция "фузипан-дерма" для лечения угревой болезни i-ii стадий
EA201201213A1 (ru) Фармацевтический состав, обладающий метаболическим, противокатарактным, ретинопротекторным действием (варианты)
EA201201212A1 (ru) Фармацевтический состав, обладающий метаболическим, противокатарактным, ретинопротекторным действием (варианты)
EA201201215A1 (ru) Фармацевтический состав, обладающий метаболическим, противокатарактным, ретинопротекторным действием (варианты)